ERBB2 and prostate carcinoma: Breast and prostate cancer: In HER2-positive breast cancer and in prostate cancer, BMP-9 again exerts tumor suppressive effects by inhibiting apoptosis, suggesting a possible reduction in the formation of cancer stem cell activity [62].